Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Increased Vulnerability to Pattern-Related Visual Stress in Myalgic Encephalomyelitis.

Wilson RL, Paterson KB, Hutchinson CV.

Perception. 2015 Dec;44(12):1422-6. doi: 10.1177/0301006615614467. Epub 2015 Nov 3.

PMID:
26562880
2.

Experiences of daily activity in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their implications for rehabilitation programmes.

Pemberton S, Cox DL.

Disabil Rehabil. 2014;36(21):1790-7. doi: 10.3109/09638288.2013.874503. Epub 2013 Dec 27.

PMID:
24369769
3.

The Pattern Glare Test: a review and determination of normative values.

Evans BJ, Stevenson SJ.

Ophthalmic Physiol Opt. 2008 Jul;28(4):295-309. doi: 10.1111/j.1475-1313.2008.00578.x.

PMID:
18565084
4.

The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Murdock KW, Wang XS, Shi Q, Cleeland CS, Fagundes CP, Vernon SD.

Qual Life Res. 2017 Apr;26(4):913-921. doi: 10.1007/s11136-016-1406-3. Epub 2016 Sep 6.

5.

The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers.

Nacul LC, Lacerda EM, Campion P, Pheby D, Drachler Mde L, Leite JC, Poland F, Howe A, Fayyaz S, Molokhia M.

BMC Public Health. 2011 May 27;11:402. doi: 10.1186/1471-2458-11-402.

6.

Pain in people with chronic fatigue syndrome/myalgic encephalomyelitis: the role of traumatic stress and coping strategies.

Krzeczkowska A, Karatzias T, Dickson A.

Psychol Health Med. 2015;20(2):210-6. doi: 10.1080/13548506.2014.951370. Epub 2014 Sep 2.

PMID:
25178481
10.

Biochemical and vascular aspects of pediatric chronic fatigue syndrome.

Kennedy G, Khan F, Hill A, Underwood C, Belch JJ.

Arch Pediatr Adolesc Med. 2010 Sep;164(9):817-23. doi: 10.1001/archpediatrics.2010.157.

PMID:
20819963
11.

Patterns of abnormal visual attention in myalgic encephalomyelitis.

Hutchinson CV, Badham SP.

Optom Vis Sci. 2013 Jun;90(6):607-14. doi: 10.1097/OPX.0b013e318294c232.

PMID:
23689679
13.

Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome.

Hoad A, Spickett G, Elliott J, Newton J.

QJM. 2008 Dec;101(12):961-5. doi: 10.1093/qjmed/hcn123. Epub 2008 Sep 19.

PMID:
18805903
14.

Optometric correlates of Meares-Irlen syndrome: a matched group study.

Evans BJ, Busby A, Jeanes R, Wilkins AJ.

Ophthalmic Physiol Opt. 1995 Sep;15(5):481-7.

PMID:
8524579
15.

Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.

Maes M.

Mod Trends Pharmacopsychiatry. 2013;28:162-74. doi: 10.1159/000343982. Epub 2013 Feb 27. Review.

PMID:
25224898
16.

Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.

Badham SP, Hutchinson CV.

Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2769-76. doi: 10.1007/s00417-013-2431-3. Epub 2013 Aug 6.

PMID:
23918092
18.

Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.

Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.

Neuro Endocrinol Lett. 2009;30(6):715-22.

PMID:
20035260
20.

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.

Landi A, Broadhurst D, Vernon SD, Tyrrell DL, Houghton M.

Cytokine. 2016 Feb;78:27-36. doi: 10.1016/j.cyto.2015.11.018. Epub 2015 Nov 28.

Supplemental Content

Support Center